Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis
Status:
Unknown status
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the potential effect of topically applied 3.75%
imiquimod cream on atrial ectopy in actinic keratosis (AK) patients. The primary endpoint is
the change in the 24-hour supraventricular premature beat count. The secondary endpoint is
the change in 24-hour supraventricular premature couplet and run counts and atrial
fibrillation (% time); change in 24-hour mean heart rate; change in 24-hour ventricular
premature beat count, ventricular premature couplet and run counts.